Annual EBITDA
-$133.99M$71.12M+34.68%
Summary
- Current Value
- As of today, TXG annual EBITDA is -$133.99M, up +34.68% on
- Historical Performance
- TXG annual EBITDA is down -444.78% over the past 3 years, and down -541.46% over the past 5 years
- All-Time High Comparison
- TXG annual EBITDA is currently -883.40% below its historical high of -$13.63M set on
- 3-Year Low Comparison
- TXG annual EBITDA is +34.68% above its 3-year low of -$205.11M reached on
- Sector Comparison
- TXG annual EBITDA is higher than 12.71% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$133.99M | +34.7% | -444.8% | -541.5% | -883.4% | |
| Quarterly EBITDA | -$19.99M | +35.0% | +37.3% | -3.0% | – | |
| TTM EBITDA | -$98.54M | +26.1% | +23.5% | -30.5% | – | |
| Price | $19.99 | +28.7% | -47.1% | -87.4% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $610.79M | -1.3% | +24.5% | +148.4% | +759.2% | |
| Annual EPS | -$1.52 | +30.4% | -187.4% | -366.9% | -670.4% | |
| Annual EBIT | -$177.70M | +28.6% | -236.2% | -535.7% | -891.0% | |
| Annual Net Income | -$182.63M | +28.4% | -213.7% | -484.4% | -873.4% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$128.49M | N/A | -4.3% |
| 5Y | -$24.60M | -444.8% | |
| All | -$13.63M | -883.4% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$205.11M | +34.7% | |
| 5Y | -$513.77M | N/A | +73.9% |
| All | -$513.77M | +73.9% |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$133.99M | +34.7% | |
| -$205.11M | -59.6% | |
| -$128.49M | -422.4% | |
| -$24.60M | +95.2% |
| Year | Value | Change |
|---|---|---|
| -$513.77M | -2,359.7% | |
| -$20.89M | +80.3% | |
| -$106.08M | -678.6% | |
| -$13.63M | - |
FAQ
What is the current annual EBITDA of TXG?
As of today, TXG annual EBITDA is -$133.99M
What is 1-year change in TXG annual EBITDA?
TXG annual EBITDA is up +34.68% year-over-year
What is 3-year change in TXG annual EBITDA?
TXG annual EBITDA is down -444.78% over the past 3 years
How far is TXG annual EBITDA from its all-time high?
TXG annual EBITDA is currently -883.40% below its historical high of -$13.63M set on December 31, 2017
How does TXG annual EBITDA rank versus sector peers?
TXG annual EBITDA is higher than 12.71% of companies in Healthcare sector
When is TXG next annual earnings release?
The next annual earnings release for TXG is on
Quarterly EBITDA
-$19.99M$19.07M-2,065.87%
Summary
- Current Value
- As of today, TXG quarterly EBITDA is -$19.99M, down -2065.87% on
- Historical Performance
- TXG quarterly EBITDA is up +34.96% year-over-year, and up +37.29% over the past 3 years
- All-Time High Comparison
- TXG quarterly EBITDA is currently -753.51% below its historical high of $3.06M set on
- 3-Year Low Comparison
- TXG quarterly EBITDA is +61.17% above its 3-year low of -$51.48M reached on
- Sector Comparison
- TXG quarterly EBITDA is higher than 21.39% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$19.99M | -2065.9% | +35.0% | +37.3% | -3.0% | |
| Annual EBITDA | -$133.99M | – | +34.7% | -444.8% | -541.5% | |
| TTM EBITDA | -$98.54M | +9.8% | +26.1% | +23.5% | -30.5% | |
| Price | $19.99 | +72.3% | +28.7% | -47.1% | -87.4% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $149.00M | -13.8% | -1.8% | +13.7% | +107.5% | |
| Quarterly EPS | -$0.22 | -178.9% | +26.1% | +40.4% | +66.3% | |
| Quarterly EBIT | -$32.24M | -204.9% | +22.3% | +19.4% | -32.8% | |
| Quarterly Net Income | -$27.47M | -179.5% | +23.2% | +34.5% | +58.3% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$923.00K | -2065.9% | |
| 3Y | -$923.00K | -2065.9% | |
| 5Y | $3.06M | N/A | -753.5% |
| All | $3.06M | -753.5% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$39.02M | N/A | +48.8% |
| 3Y | -$51.48M | +61.2% | |
| 5Y | -$54.67M | +63.4% | |
| All | -$73.90M | +73.0% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of TXG?
As of today, TXG quarterly EBITDA is -$19.99M
What is TXG quarterly EBITDA most recent change?
TXG quarterly EBITDA was down -2065.87% on September 30, 2025
What is 1-year change in TXG quarterly EBITDA?
TXG quarterly EBITDA is up +34.96% year-over-year
How far is TXG quarterly EBITDA from its all-time high?
TXG quarterly EBITDA is currently -753.51% below its historical high of $3.06M set on December 31, 2020
How does TXG quarterly EBITDA rank versus sector peers?
TXG quarterly EBITDA is higher than 21.39% of companies in Healthcare sector
When is TXG next earnings release?
The next earnings release for TXG is on
TTM EBITDA
-$98.54M$10.74M+9.83%
Summary
- Current Value
- As of today, TXG TTM EBITDA is -$98.54M, up +9.83% on
- Historical Performance
- TXG TTM EBITDA is up +26.12% year-over-year, and up +23.50% over the past 3 years
- All-Time High Comparison
- TXG TTM EBITDA is currently -652.59% below its historical high of -$13.09M set on
- 3-Year Low Comparison
- TXG TTM EBITDA is +40.37% above its 3-year low of -$165.26M reached on
- Sector Comparison
- TXG TTM EBITDA is higher than 16.97% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$98.54M | +9.8% | +26.1% | +23.5% | -30.5% | |
| Annual EBITDA | -$133.99M | – | +34.7% | -444.8% | -541.5% | |
| Quarterly EBITDA | -$19.99M | -2065.9% | +35.0% | +37.3% | -3.0% | |
| Price | $19.99 | +72.3% | +28.7% | -47.1% | -87.4% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $641.81M | -0.4% | +1.9% | +27.4% | +145.1% | |
| TTM EPS | -$0.62 | +11.0% | +59.1% | +57.6% | +53.6% | |
| TTM EBIT | -$140.82M | +6.2% | +21.0% | +12.4% | -54.9% | |
| TTM Net Income | -$76.32M | +9.8% | +58.2% | +54.4% | +43.2% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$98.54M | at high | |
| 3Y | -$98.54M | at high | |
| 5Y | -$13.09M | -652.6% | |
| All | -$13.09M | -652.6% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$148.49M | N/A | +33.6% |
| 3Y | -$165.26M | +40.4% | |
| 5Y | -$165.26M | +40.4% | |
| All | -$165.26M | +40.4% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of TXG?
As of today, TXG TTM EBITDA is -$98.54M
What is TXG TTM EBITDA most recent change?
TXG TTM EBITDA was up +9.83% on September 30, 2025
What is 1-year change in TXG TTM EBITDA?
TXG TTM EBITDA is up +26.12% year-over-year
How far is TXG TTM EBITDA from its all-time high?
TXG TTM EBITDA is currently -652.59% below its historical high of -$13.09M set on September 30, 2021
How does TXG TTM EBITDA rank versus sector peers?
TXG TTM EBITDA is higher than 16.97% of companies in Healthcare sector
When is TXG next earnings release?
The next earnings release for TXG is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- TXG Official Website www.10xgenomics.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1770787/000162828025050332/0001628280-25-050332-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1770787/000177078725000013/0001770787-25-000013-index.htm
- TXG Profile on Yahoo Finance finance.yahoo.com/quote/TXG
- TXG Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/txg